サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1709478

慢性静脈閉塞症治療市場：製品タイプ別、治療タイプ別、診断別、最終用途別、国別、地域別-2025-2032年の世界産業分析、市場規模、市場シェア、予測

Chronic Venous Occlusions Treatment Market, By Product Type, By Treatment Type, By Diagnosis, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.41円
慢性静脈閉塞症治療市場：製品タイプ別、治療タイプ別、診断別、最終用途別、国別、地域別-2025-2032年の世界産業分析、市場規模、市場シェア、予測
出版日: 2025年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

慢性静脈閉塞症治療市場規模は2024年に72億943万米ドルとなり、2025年から2032年にかけてCAGR 5.80%で拡大

慢性静脈閉塞症治療市場-市場ダイナミクス

静脈疾患の有病率の上昇と技術の進歩が慢性静脈閉塞症治療市場の成長を牽引

慢性静脈不全や深部静脈血栓症などの静脈疾患の有病率の上昇と低侵襲治療技術の進歩が、慢性静脈閉塞症（CVO）治療市場の成長を大きく牽引しています。世界保健機関（WHO）によると、静脈疾患は世界の成人人口の約30％が罹患しており、高齢化と座りっぱなしのライフスタイルが負担増の一因となっています。例えば、米国国立衛生研究所（NIH）の報告によると、米国だけでも年間60万件以上の静脈血栓塞栓症が新たに診断されています。生体吸収性ステントや改善された血栓溶解技術のような技術革新が治療成績を向上させている一方で、新興国の医療インフラを改善する政府の取り組みが市場拡大の新たな機会を生み出しています。しかし、治療費の高騰や地方における高度医療へのアクセスの制限といった課題は、依然として普及の重要な障壁となっています。

慢性静脈閉塞症治療市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2025-2032年）に約5.80%のCAGRで毎年成長すると推定されます。

製品タイプ別では、静脈ステントと抗凝固剤が2024年に最大の市場シェアを示すと予測されました。

治療タイプ別では、静脈内アブレーションと血栓溶解療法が2024年の主要治療タイプでした。

診断別では、デュプレックス超音波が2024年の主要診断でした。

地域別では、北米が2024年の売上高をリードしました。

慢性静脈閉塞症治療市場-セグメンテーション分析：

世界の慢性静脈閉塞症治療市場は、製品タイプ、治療タイプ、診断、最終用途、地域に基づいてセグメント化されます。

市場は製品タイプに基づいて4つのカテゴリーに分けられます：すなわち、圧迫ストッキング、静脈ステント、抗凝固剤、硬化療法剤、その他です。静脈ステントと抗凝固剤は、重度の閉塞に対する有効性から圧倒的なシェアを占めているが、圧迫ストッキングは早期管理や予防ケアに依然として人気があります。

市場は治療タイプによって2つに分類されます：すなわち、圧迫療法、薬物療法、静脈内焼灼療法、外科的介入、血栓溶解療法です。静脈内焼灼療法と血栓溶解療法はその低侵襲性と有効性から広く使用されていますが、圧迫療法は依然として早期管理に広く使用されています。

慢性静脈閉塞症治療市場-地理的洞察

慢性静脈閉塞症（CVO）治療市場は、ヘルスケアインフラ、疾患有病率、先進治療へのアクセスなどの違いにより、大きな地域差が見られます。北米は、静脈疾患の高い有病率、強固なヘルスケアシステム、革新的技術の早期導入に支えられて市場を独占しており、米国は深部静脈血栓症や慢性静脈不全の症例増加により大きなシェアを占めています。欧州は、特にドイツや英国のような国々における高齢化社会と政府出資のヘルスケア・イニシアチブに牽引され、その後に続いています。アジア太平洋地域は、医療費の増加、医療施設へのアクセスの改善、静脈疾患に対する意識の高まりにより、中国やインドのような国々が牽引役となり、急速な成長が見込まれています。一方、ラテンアメリカと中東・アフリカは、医療アクセスが限られているなどの課題に直面しているが、医療インフラへの投資や低侵襲治療の採用増加を通じて、徐々に市場でのプレゼンスを拡大しつつあります。

慢性静脈閉塞症治療市場-競合情勢：

慢性静脈閉塞症（CVO）治療市場は、既存医療機器企業、新興企業、技術革新と市場拡大を目的とした戦略的提携の存在によって特徴づけられる競合情勢を特徴とします。メドトロニック、ボストン・サイエンティフィック、フィリップスヘルスケアなどの主要企業が市場を独占し、広範な製品ポートフォリオと強力な流通網を活用して競争力を維持しています。これらの企業は研究開発に積極的に投資し、生体吸収性ステントや次世代血栓溶解装置などの先進的ソリューションを導入しています。中小企業や新興企業も、ニッチなセグメントや費用対効果の高い治療に注力することで牽引力を増しています。戦略的提携、合併、買収は一般的であり、これは企業が技術力と地理的範囲を強化することを目的としているためです。さらに、規制当局の承認と臨床試験は競争力学の形成に重要な役割を果たしており、各社は厳しい安全性と有効性の基準を満たすべく努力しています。市場の競争激化は、低侵襲治療への需要の高まりと静脈疾患の世界の有病率の増加によってさらに拍車がかかっています。

目次

第1章 慢性静脈閉塞症治療市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 慢性静脈閉塞症治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 慢性静脈閉塞症治療産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 慢性静脈閉塞症治療市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 慢性静脈閉塞症治療市場情勢

  • 慢性静脈閉塞症治療市場シェア分析（2024年）
  • 主要メーカー別内訳データ
    • ベテラン企業の分析
    • 新興企業の分析

第7章 慢性静脈閉塞症治療市場-製品タイプ

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 着圧ストッキング
    • 静脈ステント
    • 抗凝固薬
    • 硬化療法剤
    • その他

第8章 慢性静脈閉塞症治療市場-治療タイプ別

  • 概要
    • 治療タイプ別セグメントシェア分析
    • 圧迫療法
    • 薬物治療
    • 静脈内アブレーション
    • 外科的介入
    • 血栓溶解療法

第9章 慢性静脈閉塞症治療市場- 診断別

  • 概要
    • 診断別セグメントシェア分析
    • デュプレックス超音波
    • 静脈造影検査
    • 磁気共鳴静脈造影検査
    • その他

第10章 慢性静脈閉塞症治療市場- 最終用途別

  • 概要
    • 最終用途別セグメントシェア分析
    • 病院
    • 外来手術センター
    • 専門クリニック
    • 在宅ケア設定

第11章 慢性静脈閉塞症治療市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ（MEA）
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 慢性静脈閉塞症治療業界

  • 競合ダッシュボード
    • Competitive Benchmarking
    • Competitive Positioning
  • 企業プロファイル
    • Abbott Laboratories
    • AngioDynamics, Inc.
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • BTG International Ltd.
    • Cardinal Health, Inc.
    • Cook Medical
    • Endologix, Inc.
    • Koninklijke Philips NV
    • LeMaitre Vascular, Inc.
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • Stryker Corporation
    • Teleflex Incorporated
    • Terumo Corporation
    • Vascular Solutions, Inc.
    • Others

第13章 アナリストの全方位的展望

目次
Product Code: ANV4913

REPORT HIGHLIGHT

Chronic Venous Occlusions Treatment Market size was valued at US$ 7,209.43 Million in 2024, expanding at a CAGR of 5.80% from 2025 to 2032.

The Chronic Venous Occlusions (CVO) Treatment Market focuses on addressing blockages in the venous system, often caused by deep vein thrombosis or chronic venous insufficiency, through interventions like angioplasty, stenting, and thrombolysis. Increasing prevalence of venous diseases, advancements in minimally invasive surgical techniques, and rising awareness about early diagnosis are propelling market growth, with over 30% of adults estimated to suffer from some form of venous disorder globally. However, high treatment costs and limited access to advanced healthcare in developing regions act as significant restraints. Opportunities lie in the development of innovative bioabsorbable stents and the expansion of telemedicine for post-treatment care, particularly in underserved areas. Additionally, the growing aging population, which is more susceptible to venous disorders, further underscores the potential for market expansion.

Chronic Venous Occlusions Treatment Market- Market Dynamics

Rising Prevalence of Venous Disorders and Technological Advancements to Drive Chronic Venous Occlusions Treatment Market Growth

The rising prevalence of venous disorders, such as chronic venous insufficiency and deep vein thrombosis, coupled with advancements in minimally invasive treatment technologies, is significantly driving the growth of the Chronic Venous Occlusions (CVO) Treatment Market. According to the World Health Organization (WHO), venous diseases affect approximately 30% of the global adult population, with aging populations and sedentary lifestyles contributing to the increasing burden. For instance, the National Institutes of Health (NIH) reports that over 600,000 new cases of venous thromboembolism are diagnosed annually in the United States alone. Innovations like bioabsorbable stents and improved thrombolysis techniques are enhancing treatment outcomes, while government initiatives to improve healthcare infrastructure in emerging economies are creating new opportunities for market expansion. However, challenges such as high treatment costs and limited access to advanced care in rural areas remain critical barriers to widespread adoption.

Chronic Venous Occlusions Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.80% over the forecast period (2025-2032)

Based on product type segmentation, Venous stents and anticoagulants was predicted to show maximum market share in the year 2024

Based on Treatment Type segmentation, Endovenous ablation and thrombolytic therapy was the leading Treatment Type in 2024

Based on Diagnosis segmentation, Duplex Ultrasound was the leading Diagnosis in 2024

On the basis of region, North America was the leading revenue generator in 2024

Chronic Venous Occlusions Treatment Market- Segmentation Analysis:

The Global Chronic Venous Occlusions Treatment Market is segmented on the basis of Product Type, Treatment Type, Diagnosis, End-User, and Region.

The market is divided into four categories based on product type: Compression stockings, venous stents, anticoagulants, sclerotherapy agents, and others. Venous stents and anticoagulants dominate due to their efficacy in treating severe occlusions, while compression stockings remain popular for early-stage management and preventive care.

The market is divided into two categories based on Treatment Type: Compression therapy, pharmacological treatment, endovenous ablation, surgical interventions, and thrombolytic therapy. Endovenous ablation and thrombolytic therapy are widely used due to their minimally invasive nature and effectiveness, while compression therapy remains widely used for early-stage management.

Chronic Venous Occlusions Treatment Market- Geographical Insights

The Chronic Venous Occlusions (CVO) Treatment Market exhibits significant regional variation, driven by differences in healthcare infrastructure, disease prevalence, and access to advanced treatments. North America dominates the market, supported by a high prevalence of venous disorders, robust healthcare systems, and early adoption of innovative technologies, with the U.S. accounting for a substantial share due to rising cases of deep vein thrombosis and chronic venous insufficiency. Europe follows closely, driven by aging populations and government-funded healthcare initiatives, particularly in countries like Germany and the UK. The Asia-Pacific region is expected to witness rapid growth due to increasing healthcare expenditure, improving access to medical facilities, and a growing awareness of venous diseases, with countries like China and India leading the way. Meanwhile, Latin America and the Middle East & Africa face challenges such as limited healthcare access but are gradually expanding their market presence through investments in healthcare infrastructure and rising adoption of minimally invasive treatments.

Chronic Venous Occlusions Treatment Market- Competitive Landscape:

The Chronic Venous Occlusions (CVO) Treatment Market features a competitive landscape characterized by the presence of established medical device companies, emerging players, and strategic collaborations aimed at innovation and market expansion. Key players such as Medtronic, Boston Scientific, and Philips Healthcare dominate the market, leveraging their extensive product portfolios and strong distribution networks to maintain a competitive edge. These companies are actively investing in research and development to introduce advanced solutions like bioabsorbable stents and next-generation thrombolysis devices. Smaller firms and startups are also gaining traction by focusing on niche segments and cost-effective treatments. Strategic partnerships, mergers, and acquisitions are common, as companies aim to enhance their technological capabilities and geographic reach. Additionally, regulatory approvals and clinical trials play a crucial role in shaping the competitive dynamics, with players striving to meet stringent safety and efficacy standards. The market's competitive intensity is further fueled by increasing demand for minimally invasive treatments and the growing prevalence of venous disorders worldwide.

Recent Developments:

In June 2024, Philips has launched the Duo Venous Stent System, a device to treat symptomatic venous outflow obstruction in chronic venous insufficiency (CVI) patients. The system, comprised of two stents, is designed for the unique challenges of venous anatomy and demonstrated safety and efficacy in the VIVID study.

In July 2024, Inari expanded its device portfolio with FDA-cleared VenaCore, a minimally invasive thrombectomy catheter for peripheral vasculature. Featuring a notched coring element and collapsible handle, VenaCore efficiently debulks and removes tough venous occlusions, enhancing treatment for complex vascular blockages.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cardinal Health, Inc.
  • Cook Medical
  • Endologix, Inc.
  • Koninklijke Philips N.V.
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vascular Solutions, Inc.
  • Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Compression Stockings
  • Venous Stents
  • Anticoagulants
  • Sclerotherapy Agents
  • Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Compression Therapy
  • Pharmacological Treatment
  • Endovenous Ablation
  • Surgical Interventions
  • Thrombolytic Therapy

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Duplex Ultrasound
  • Venography
  • Magnetic Resonance Venography
  • Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home Care Settings

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chronic Venous Occlusions Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chronic Venous Occlusions Treatment Market Snippet by Product Type
    • 2.1.2. Chronic Venous Occlusions Treatment Market Snippet by Treatment Type
    • 2.1.3. Chronic Venous Occlusions Treatment Market Snippet by Diagnosis
    • 2.1.4. Chronic Venous Occlusions Treatment Market Snippet by End-User
    • 2.1.5. Chronic Venous Occlusions Treatment Market Snippet by Country
    • 2.1.6. Chronic Venous Occlusions Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Chronic Venous Occlusions Treatment Key Market Trends

  • 3.1. Chronic Venous Occlusions Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chronic Venous Occlusions Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chronic Venous Occlusions Treatment Market Opportunities
  • 3.4. Chronic Venous Occlusions Treatment Market Future Trends

4. Chronic Venous Occlusions Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chronic Venous Occlusions Treatment Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Chronic Venous Occlusions Treatment Market Landscape

  • 6.1. Chronic Venous Occlusions Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chronic Venous Occlusions Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Compression Stockings
    • 7.1.3. Venous Stents
    • 7.1.4. Anticoagulants
    • 7.1.5. Sclerotherapy Agents
    • 7.1.6. Others

8. Chronic Venous Occlusions Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 8.1.2. Compression Therapy
    • 8.1.3. Pharmacological Treatment
    • 8.1.4. Endovenous Ablation
    • 8.1.5. Surgical Interventions
    • 8.1.6. Thrombolytic Therapy

9. Chronic Venous Occlusions Treatment Market - By Diagnosis

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Diagnosis, 2024 & 2032 (%)
    • 9.1.2. Duplex Ultrasound
    • 9.1.3. Venography
    • 9.1.4. Magnetic Resonance Venography
    • 9.1.5. Others

10. Chronic Venous Occlusions Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers
    • 10.1.4. Specialty Clinics
    • 10.1.5. Home Care Settings

11. Chronic Venous Occlusions Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Chronic Venous Occlusions Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Chronic Venous Occlusions Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Chronic Venous Occlusions Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Chronic Venous Occlusions Treatment Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Chronic Venous Occlusions Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Chronic Venous Occlusions Treatment Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. AngioDynamics, Inc.
    • 12.2.3. Becton, Dickinson and Company
    • 12.2.4. Boston Scientific Corporation
    • 12.2.5. BTG International Ltd.
    • 12.2.6. Cardinal Health, Inc.
    • 12.2.7. Cook Medical
    • 12.2.8. Endologix, Inc.
    • 12.2.9. Koninklijke Philips N.V.
    • 12.2.10. LeMaitre Vascular, Inc.
    • 12.2.11. Medtronic plc
    • 12.2.12. Merit Medical Systems, Inc.
    • 12.2.13. Stryker Corporation
    • 12.2.14. Teleflex Incorporated
    • 12.2.15. Terumo Corporation
    • 12.2.16. Vascular Solutions, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us